That said, multiple recent Cochrane reviews found that taking the GLP-1 medications offered by Ro — semaglutide and tirzepatide — can result in meaningful weight loss. Users lose an average of 11-16% ...

Ro, a direct-to-consumer virtual health company, is diving into the weight management space with the launch of a new product offering aimed at helping patients shed the pounds. Ro, best-known for its ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Ro said it will offer a "complete end-to-end" experience on a single platform and app, allowing eligible patients to receive a diagnosis and a prescription for Zepbound and have vials of the drug ...

Ro is a telehealth company that offers virtual consultations and prescriptions for various health concerns, including GLP-1 weight-loss medications. The Ro Body program includes a monthly membership ...

Maintaining a healthy weight is one of the most crucial aspects of improving your overall wellness. From heart health to ...

Telehealth company Ro launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S. The tool could be ...

Ro is taking bets on the weight loss industry with a $30 million prepaid order of diet pill Plenity. The New York-based company inked a deal with Plenity creator Gelesis in 2019 to offer the product ...

Telehealth company Ro has paused advertising of the obesity drug Wegovy as the drug suffers shortages, a reversal in aggressive promotional efforts by the provider that involved splashy ads in subway ...